TNNT2 and coronary artery disorder: Then in order to investigate the role of the predicted Framingham CHD risk in the relationship between eGFR and hs-cTnT, we evaluate the association between high predicted Framingham CHD risk (10-year risk ≥20%) and detectable hs-cTnT in subjects with different quartile levels of eGFR.